Cefuroxime (Ceftin (po), Kefurox, Zinacef)

Category:

Antibiotic

Description:

Cephalosporin, Second Generation

Indications:

  • Oral tablets/suspension:

    • pharyngitis/tonsillitis (S. pyogenes)

    • otitis media (S. pneumoniae, H. influenzae, M. catarrhalis, S. pyogenes)

    • acute bacterial maxillary sinusitis (S. pneumoniae, H. influenzae)

    • acute bacterial exacerbation of chronic bronchitis, secondary infections due to acute bronchitis (S. pneumoniae, H. influenzae, H. parainfluenzae)

    • urinary tract infections (E. coli, K. pneumoniae)

    • skin infections (S. aureus, S. pyogenes)

    • uncomplicated gonorrhea (N. gonorrhoeae)

    • early Lyme disease (Borrelia burgdorferi)

  • Parenteral

    • lower respiratory tract (S. pneumoniae, H. influenzae, Klebsiella species, S. aureus, S. pyogenes, E. coli)

    • urinary tract infections (E. coli, K. pneumoniae)

    • septicemia (S. pneumoniae, H. influenzae, Klebsiella species, S. aureus, S. pyogenes, E. coli)

    • meningitis (N. meningitidis)

    • gonorrhea (N. gonorrhoeae)

    • skin, bone and joint infections (S. aureus, S. pyogenes, Enterobacter species, Klebsiella species, E. coli)

Contraindications:

  • Cross sensitivity with penicillin allergies

Precautions:

  • Pregnancy category B

  • Use with caution in patients with penicillin allergy (5-10% chance of cross-reactivity)

  • Dosage modifications are generally only required in patients with severe renal impairment

  • Counsel patient to finish all medication to prevent development of resistance

  • Do not crush tablets, swallow whole or use suspension dosing

  • NOTE: oral tablets and suspension are NOT bioequivalent

Adverse Reactions (Side Effects):

  • Hypersensitivity reactions

  • Gastrointestinal: nausea, vomiting, diarrhea

  • Vaginitis

 

Dosage:

  • Administered orally (tablets and suspension) and by injection (IV or IM)

  • Pharyngitis/tonsillitis:

    • Adults (> 13 years): 250mg bid for 10 days

    • Children: 125mg tablets bid for 10 days or 20mg/kg/day (susp) divided bid for 10 days

  • Otitis media:

    • Adults (>13 years): 250mg bid for 10 days

    • Children: 250mg tablets bid for 10 days or 30mg/kg/day (susp) divided bid for 10 days

  • Impetigo:

    • 30mg/kg/day (susp) divided bid for 10 days

  • Acute bacterial exacerbation of chronic bronchitis/secondary infections of to acute bronchitis:

    • Adults (> 13 years): 250-500mg bid for 5-10 days

  • Urinary tract infections:

    • Adults: 125-250mg bid tablets for 7-10 days or 2.25 grams per day (750mg q8h IV)

  • Uncomplicated skin infections:

    • Adults: 250-500mg bid tablets for 10 days or 2.25 grams per day (750mg q8h IV)

  • Uncomplicated gonorrhea infections:

    • 1000mg tablets one dose or 1.5 grams IM one dose

  • Disseminated gonococcal:

    • 2.25 grams per day (750mg q8h IV)

  • Early Lyme disease:

    • Adults: 500mg bid for 20 days

  • Uncomplicated pneumonia:

    • 2.25 grams per day (750mg q8h IV)

  • Severe or complicated infections and bone or joint infections:

    • 4.5 grams per day (1.5 grams q8h IV)

  • Life-threatening infections:

    • 6 grams per day (1.5 grams q6h IV)

  • Bacterial meningitis:

    • 9 grams per day (<3 grams q8h IV)

 

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

Approved for public release; Distribution is unlimited.

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.

Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates, LLC.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

© 2015, Brookside Associates, LLC. All rights reserved

Other Brookside Products

 

 

Advertise on this site